Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    External links to PubMed and U.S. government sites were removed from the page footer. The core study details and page structure remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T00:57:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now includes new external references, including a PubMed publication (40598566), and links to government sites such as HHS, NIH, NLM, NCBI, and USA.gov. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-26T20:30:13.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated system to revision v3.2.0 and added a government operating status notice; removed the previous No Results Posted and v3.1.0 references.
    Difference
    4%
    Check dated 2025-10-05T08:35:07.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:03:55.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.3%
    Check dated 2025-09-13T16:47:01.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-06T14:08:45.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.